BANDICOOT is a world‑first adaptive platform trial dedicated to improving the health outcomes of critically ill children undergoing haematopoietic stem cell transplant (HCT), also known as a bone marrow transplant.
Using an innovative adaptive platform trial design, BANDICOOT can test multiple